Cargando…

Changes in Lipoprotein(a) Levels in People after ST Elevation Myocardial Infarction—The STEMI-Lipids Study

Lipoprotein(a) (Lp(a)) is considered an independent risk factor for cardiovascular diseases. The plasma concentration of Lp(a) is largely genetically determined but varies over a wide range within the population. This study investigated changes in Lp(a) levels after an acute myocardial infarction. P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sourij, Caren, Aziz, Faisal, Krappinger, Sarah, Praschk, Andreas, Metzner, Thomas, Kojzar, Harald, Zirlik, Andreas, Stojakovic, Tatjana, Pätzold, Dieter, von Lewinski, Dirk, Zweiker, Robert, Scharnagl, Hubert, Sourij, Harald
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647358/ https://www.ncbi.nlm.nih.gov/pubmed/37958516 http://dx.doi.org/10.3390/ijms242115531

Ejemplares similares

Hypoglycaemia leads to a delayed increase in platelet and coagulation activation markers in people with type 2 diabetes treated with metformin only: Results from a stepwise hypoglycaemic clamp study
por: Aberer, Felix, et al.
Publicado: (2019)

Albumin of People with Diabetes Mellitus Is More Reduced at Low HbA1c
por: Paar, Margret, et al.
Publicado: (2023)

Performance of the Intermittently Scanned Continuous Glucose Monitoring (isCGM) System during a High Oral Glucose Challenge in Adults with Type 1 Diabetes—A Prospective Secondary Outcome Analysis
por: Moser, Othmar, et al.
Publicado: (2021)

Effects of Alirocumab on Triglyceride Metabolism: A Fat-Tolerance Test and Nuclear Magnetic Resonance Spectroscopy Study
por: Metzner, Thomas, et al.
Publicado: (2022)

INTERmittent FASTing in people with insulin‐treated type 2 diabetes mellitus – the INTERFAST‐2 study protocol
por: Obermayer, Anna, et al.
Publicado: (2022)

EndoBarrier™ Implantation Rapidly Improves Insulin Sensitivity in Obese Individuals with Type 2 Diabetes Mellitus
por: Obermayer, Anna, et al.
Publicado: (2021)

Simplified Acute Physiology Score 3 Performance in Austrian COVID-19 Patients Admitted to Intensive Care Units with and without Diabetes
por: Aziz, Faisal, et al.
Publicado: (2022)

Rapid glucose rise reduces heart rate variability in adults with type 1 diabetes: A prospective secondary outcome analysis
por: Eckstein, Max L., et al.
Publicado: (2021)

Efficacy and Safety of Intermittent Fasting in People With Insulin-Treated Type 2 Diabetes (INTERFAST-2)—A Randomized Controlled Trial
por: Obermayer, Anna, et al.
Publicado: (2023)

Impact of the SGLT2-inhibitor empagliflozin on inflammatory biomarkers after acute myocardial infarction – a post-hoc analysis of the EMMY trial
por: Benedikt, Martin, et al.
Publicado: (2023)

Pre-Exercise Blood Glucose Levels Determine the Amount of Orally Administered Carbohydrates during Physical Exercise in Individuals with Type 1 Diabetes—A Randomized Cross-Over Trial
por: Moser, Othmar, et al.
Publicado: (2019)

Impact of Duodeno-Jejunal Bypass Liner (EndoBarrierTM) Implantation on Insulin Sensitivity in Patients with Type 2 Diabetes Mellitus (T2DM): A Study Protocol for a Pilot Trial
por: Tripolt, Norbert Joachim, et al.
Publicado: (2018)

Improved glycaemic variability and basal insulin dose reduction during a running competition in recreationally active adults with type 1 diabetes—A single-centre, prospective, controlled observational study
por: Moser, Othmar, et al.
Publicado: (2020)

Severe acute respiratory syndrome coronavirus 2 spike antibody level decline is more pronounced after the second vaccination, but response to the third vaccination is similar in people with type 1 and type 2 diabetes compared with healthy controls: The prospective COVAC‐DM cohort study
por: Sourij, Caren, et al.
Publicado: (2022)

Short-Term Treatment with Alirocumab, Flow-Dependent Dilatation of the Brachial Artery and Use of Magnetic Resonance Diffusion Tensor Imaging to Evaluate Vascular Structure: An Exploratory Pilot Study
por: Metzner, Thomas, et al.
Publicado: (2022)

Comment on: Davidson et al. High-Dose Vitamin D Supplementation in People With Prediabetes and Hypovitaminosis D. Diabetes Care 2013;36:260–266
por: Tripolt, Norbert J., et al.
Publicado: (2013)

Reduction in insulin degludec dosing for multiple exercise sessions improves time spent in euglycaemia in people with type 1 diabetes: A randomized crossover trial
por: Moser, Othmar, et al.
Publicado: (2018)

Alterations in trimethylamine-N-oxide in response to Empagliflozin therapy: a secondary analysis of the EMMY trial
por: Aziz, Faisal, et al.
Publicado: (2023)

Identification of Novel Intronic SNPs in Transporter Genes Associated with Metformin Side Effects
por: Schweighofer, Natascha, et al.
Publicado: (2023)

Revisiting the Diabetes-Heart Failure Connection
por: Wallner, Markus, et al.
Publicado: (2018)

Alteration of circulating platelet-related and diabetes-related microRNAs in individuals with type 2 diabetes mellitus: a stepwise hypoglycaemic clamp study
por: Eyileten, Ceren, et al.
Publicado: (2022)

Only Subclinical Alterations in the Haemostatic System of People with Diabetes after COVID-19 Vaccination
por: Paar, Margret, et al.
Publicado: (2022)

Effects of linagliptin on endothelial function and postprandial lipids in coronary artery disease patients with early diabetes: a randomized, placebo-controlled, double-blind trial
por: Tripolt, Norbert J., et al.
Publicado: (2018)

Short-term effects of high-dose oral vitamin D3 in critically ill vitamin D deficient patients: a randomized, double-blind, placebo-controlled pilot study
por: Amrein, Karin, et al.
Publicado: (2011)

New Antihyperglycemic Drugs and Heart Failure: Synopsis of Basic and Clinical Data
por: von Lewinski, Dirk, et al.
Publicado: (2017)

Impact of Sepsis on High-Density Lipoprotein Metabolism
por: Reisinger, Alexander C., et al.
Publicado: (2022)

Impact of a Single 36 Hours Prolonged Fasting Period in Adults With Type 1 Diabetes – A Cross-Over Controlled Trial
por: Moser, Othmar, et al.
Publicado: (2021)

Glucose Metabolism and Metabolomic Changes in Response to Prolonged Fasting in Individuals with Obesity, Type 2 Diabetes and Non-Obese People—A Cohort Trial
por: Tripolt, Norbert J., et al.
Publicado: (2023)

Diabetes mellitus is independently associated with adverse clinical outcome in soft tissue sarcoma patients
por: Stelzl, Adrian, et al.
Publicado: (2020)

The effects of linagliptin on endothelial function and global arginine bioavailability ratio in coronary artery disease patients with early diabetes: study protocol for a randomized controlled trial
por: Tripolt, Norbert J., et al.
Publicado: (2016)

Urinary C-Peptide to Creatinine Ratio (UCPCR) as Indicator for Metabolic Risk in Apparently Healthy Adults—A BioPersMed Cohort Study
por: Reintar, Sharmaine, et al.
Publicado: (2023)

Agreement between cardiovascular disease risk assessment tools: An application to the United Arab Emirates population
por: Oulhaj, Abderrahim, et al.
Publicado: (2020)

Diabetic Cardiomyopathy: Current and Future Therapies. Beyond Glycemic Control
por: Borghetti, Giulia, et al.
Publicado: (2018)

SGLT2 Inhibitors and Their Antiarrhythmic Properties
por: Kolesnik, Ewald, et al.
Publicado: (2022)

Comparison of Two Nuclear Magnetic Resonance Spectroscopy Methods for the Measurement of Lipoprotein Particle Concentrations
por: Rief, Martin, et al.
Publicado: (2022)

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: guidelines, clinical reality and health economic aspects
por: Toplak, Hermann, et al.
Publicado: (2016)

COVID‐19 fatality prediction in people with diabetes and prediabetes using a simple score upon hospital admission
por: Sourij, Harald, et al.
Publicado: (2020)

Time in Range for Closed-Loop Systems versus Standard of Care during Physical Exercise in People with Type 1 Diabetes: A Systematic Review and Meta-Analysis
por: Eckstein, Max L., et al.
Publicado: (2021)

Impact of Endothelial Lipase on Cholesterol Efflux Capacity of Serum and High-density Lipoprotein
por: Schilcher, Irene, et al.
Publicado: (2017)

Humoral immune response to COVID‐19 vaccination in diabetes is age‐dependent but independent of type of diabetes and glycaemic control: The prospective COVAC‐DM cohort study
por: Sourij, Caren, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8o3rqbn4d99sj87k7ohtv7plv5